Clinical Study Results
Research Sponsor: MedImmune LLC, a wholly owned subsidiary of
AstraZeneca
Drug Studied: MEDI7219
Study Purpose: This study was done to learn about
the safety of different doses and
formulations of MEDI7219 in
healthy participants
Protocol Number: D8170C00001
Thank you
Thank you for taking part in the clinical study for the study drug MEDI7219.
MedImmune sponsored this study and believes it is important to share the
results. An independent non-profit organization called CISCRP helped prepare
this summary of the study results for you.
If you participated in the study and have questions about the results, please
speak with the study doctor or staff at your study site.
1